Yorvipath to be available in the U.S. Mid-January

November 14, 2024

Yorvipath will begin rolling out Mid-January.

Patients will need to sign up for Ascendis Signature Access Program (ASAP) through their provider. This process will begin in December, watch for more information as it gets closer.

Patients in the clinical trial or on EAP will be given early access for the ASAP program as to make sure they do not need to transition off of medication. All trial and EAP sites have been notified about the program and how to proceed. Please contact your site to begin the process.

Back to News